Page last updated: 2024-11-04

rolipram and Cryptogenic Fibrosing Alveolitis

rolipram has been researched along with Cryptogenic Fibrosing Alveolitis in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Rolipram (0."1.35Rolipram attenuates bleomycin A5-induced pulmonary fibrosis in rats. ( Hou, YH; Pan, JB; Zhang, GJ, 2009)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Maher, TM1
Wells, AU1
Pan, JB1
Hou, YH1
Zhang, GJ1

Other Studies

2 other studies available for rolipram and Cryptogenic Fibrosing Alveolitis

ArticleYear
Lost in translation; from animal models of pulmonary fibrosis to human disease.
    Respirology (Carlton, Vic.), 2009, Volume: 14, Issue:7

    Topics: Animals; Bleomycin; Cyclic AMP; Cytokines; Disease Models, Animal; Humans; Idiopathic Pulmonary Fibr

2009
Rolipram attenuates bleomycin A5-induced pulmonary fibrosis in rats.
    Respirology (Carlton, Vic.), 2009, Volume: 14, Issue:7

    Topics: Animals; Bleomycin; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Cytokines; Disease Mod

2009